Unitary Pharmaceutical Dosage Form Comprising Tenofovir Df

Patent No. EP2386294 (titled "Unitary Pharmaceutical Dosage Form Comprising Tenofovir Df") was filed by Bristol Myers Squibb & Gilead Sciences on Jun 13, 2006. The application was issued on Mar 4, 2015.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACCORD HEALTHCAREDec 4, 2015ISARPATENT
HETERO DRUGSDec 4, 2015HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
SANDOZDec 4, 2015TER MEER UND PARTNER
KELTIEDec 3, 2015MOORE
STRAWMANDec 2, 2015MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2386294

BRISTOL MYERS SQUIBB & GILEAD SCIENCES
Application Number
EP11167101A
Filing Date
Jun 13, 2006
Status
Revoked
May 10, 2022
Publication Date
Mar 4, 2015